The flexible GnRH [gonadotrophin releasing hormone] antagonist [ganirelix] [Orgalutran] protocol provides better results (IVF outcomes) [invitro fertilisation] than flare up GnRH agonist [triptorelin] [Arvekap] protocol in poor responders

Trial Profile

The flexible GnRH [gonadotrophin releasing hormone] antagonist [ganirelix] [Orgalutran] protocol provides better results (IVF outcomes) [invitro fertilisation] than flare up GnRH agonist [triptorelin] [Arvekap] protocol in poor responders

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2008

At a glance

  • Drugs Ganirelix (Primary) ; Triptorelin (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top